Areas of Urology and Research
Endoscopic treatment of upper tract transitional cell carcinoma.
Overexpression of alpha-defensin is associated with bladder cancer invasiveness.
A phase II clinical trial of oral bropirimine in combination with intravesical bacillus Calmette-Guérin for carcinoma in situ of the bladder:
a Southwest Oncology Group Study.
Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update.
Clinical and consumer trial performance of a sensitive immunodiagnostic home
test that qualitatively detects low concentrations of sperm following vasectomy.
Herniorrhaphy with polypropylene mesh causing inguinal vasal obstruction: a preventable cause of obstructive azoospermia.
Isolation and enrichment of murine spermatogonial stem cells using rhodamine
123 mitochondrial dye.
Single center experience with percutaneous and laparoscopic cryoablation of small renal masses.
Molecular signatures of localized clear cell renal cell carcinoma to predict disease-free survival after nephrectomy.
Partial nephrectomy: a contemporary review regarding outcomes and different techniques.
Cancer-specific survival outcomes among patients treated during the cytokine era of kidney cancer (1989-2005): a benchmark for emerging targeted cancer therapies.
Brain metastasis from renal cell carcinoma: presentation, recurrence, and survival.
Performance status and cytoreductive nephrectomy: redefining management in patients with poor performance.
Neoadjuvant targeted therapy and advanced kidney cancer: observations and implications for a new treatment paradigm.
Tumor size does not predict risk of metastatic disease or prognosis of small renal cell carcinomas.
Hypoxia-inducible factor 1 alpha in clear cell renal cell carcinoma.
Update on partial nephrectomy and novel techniques.
The chemokine receptor CXCR3 is an independent prognostic factor in patients with localized clear cell renal cell carcinoma.
Prognostic factors for renal cell carcinoma with tumor thrombus extension.
Combined external beam radiotherapy and Pd-103 brachytherapy boost improves biochemical failure free survival in patients with clinically localized
prostate cancer: results of a matched pair analysis.
Integrated data from 2 randomized, double-blind, placebo-controlled, phase 3 trials of active cellular immunotherapy with sipuleucel-T in advanced prostate cancer.
High-grade prostate cancer and the prostate cancer prevention trial.
Glycomic characterization of prostate-specific antigen and prostatic acid phosphatase in prostate cancer and benign disease seminal plasma fluids.
Practical system of assessment: an updated acronym for PSA.
Placebo-controlled phase III trial of immunologic therapy with sipuleucel-T (APC8015) in patients with metastatic, asymptomatic hormone refractory prostate cancer.
Timing of androgen deprivation therapy: some questions answered, others not.
Re: Editorial comment on Laparoscopic radical prostatectomy: is intact organ removal attainable? Study of margin status.
Immunotherapy with autologous antigen presenting cells for the treatment of
androgen independent prostate cancer.
Single center experience with third-generation cryosurgery for management of organ-confined prostate cancer: critical evaluation of short-term outcomes,
complications, and patient quality of life.
Postoperative robotic telerounding: a multicenter randomized assessment of patient outcomes and satisfaction.
Computer modeling technology to assess extracapsular tissue coverage of whole mount sections after retropubic and laparoscopic radical prostatectomy.
Prospective longitudinal comparative study of early health-related quality-of-life outcomes in patients undergoing surgical treatment for
localized prostate cancer: a short-term evaluation of five approaches from a single institution.
Laparoscopic radical prostatectomy: evaluation of specimen pathologic features to critically assess and modify surgical technique.
Prospective longitudinal comparative study of health-related quality of life in patients undergoing invasive treatments for localized prostate cancer.
Open-label trial evaluating the safety and efficacy of zoledronic acid in preventing bone loss in patients with hormone-sensitive prostate cancer and
Modified running vesicourethral anastomosis after robotically assisted laparoscopic radical prostatectomy: use of solitary Lapra-Ty to secure
Clinical Collection and Protein Properties of Expressed Prostatic Secretions as a Source for Biomarkers of Prostatic Disease.
Peyronie's disease: update on medical management and surgical tips.
The use of intralesional clostridial collagenase injection therapy for Peyronie's disease: a prospective, single-center, non-placebo-controlled study.
The use of collagenase in the treatment of Peyronie's disease M.K. Gelbard, A. Lindner, and J.J. Kaufman.
Management of recurrent anastomotic stenosis following radical prostatectomy using holmium laser and steroid injection.
Vessel-sparing excision and primary anastomosis (for proximal bulbar urethral strictures).
Long-term follow-up for reconstruction of strictures of the fossa navicularis with a single technique.
Long-term followup for excision and primary anastomosis for anterior urethral strictures.
The technique of vessel sparing excision and primary anastomosis for proximal bulbous urethral reconstruction.
Reconstruction and management of posterior urethral and straddle injuries of the urethra.
Primary urethral reconstruction: the cost minimized approach to the bulbous urethral stricture.
Hounsfield unit density accurately predicts ESWL success.
Urodynamic Changes and Initial Results of the AdVance Male Sling.
Usefulness of adrenal vein sampling in the evaluation of aldosteronism.